ClobetasolThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you your search results in order of date.

Pages: 1 2 3

146 records returned

CORMAX (Clobetasol Propionate) Ointment [DPT Laboratories, Ltd.]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Jan 28, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - January 28, 2010 Category: Drugs & Pharmacology Source Type: organizations

CORMAX (Clobetasol Propionate) Ointment [Watson Pharma, Inc. ]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Jan 27, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - January 27, 2010 Category: Drugs & Pharmacology Source Type: organizations

Topical hydrocortisone, clobetasol propionate, and calcipotriol do not increase photocarcinogenesis induced by simulated solar irradiation in hairless miceEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Please cite this paper as: Topical hydrocortisone, clobetasol propionate, and calcipotriol do not increase photocarcinogenesis induced by simulated solar irradiation in hairless mice. Experimental Dermatology 2010.Abstract: Topical corticosteroids such as hydrocortisone-17-butyrate (HCB) and clobetasol-17-propionate (CP) and vitamin D3 derivatives such as calcipotriol (CAL) are widely used to treat psoriasis. The immunosuppressive effects of corticosteroids make their topical use a concern for skin carcinogenicity. Few studies have assessed the effect of topical corticosteroids and topical vitamin D3 derivatives on photoca...
Source: Experimental Dermatology - January 25, 2010 Category: Dermatology Authors: Catharina M. Lerche, Peter A. Philipsen, Thomas Poulsen, Hans Christian Wulf Source Type: journals

CLOBETASOL PROPIONATEaerosol, Foam [Prasco LLC]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Jan 19, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - January 19, 2010 Category: Drugs & Pharmacology Source Type: organizations

Rapid resolution of primary vulval adult Langerhans cell histiocytosis with very potent topical corticosteroidsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
We report a 62-year-old female patient presenting with an 18-month history of pruritus and burning of the vulva. Clinical examination of the vulva showed a tender nodule of the right labium minus. Histology confirmed Langerhans cell histiocytosis. Systemic involvement was excluded. Within 1 month the use of clobetasol propionate ointment led to resolution of both the patient's symptoms and the clinical appearance of the affected right labium minus. This resolution was maintained 12 months later. (Source: Australasian Journal of Dermatology)
Source: Australasian Journal of Dermatology - December 29, 2009 Category: Dermatology Authors: Susan Foley, Katherine Panting, Hazel Bell, Niamh Leonard, Andrea Franks Source Type: journals

Erosive pustular dermatosis of the leg: Long-term control with topical tacrolimusEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
We report the cases of two women who developed erythematous skin plaques with pustules that coalesced and evolved into erosions and crusted areas. Histology showed epidermal spongiosis with subcorneal pustules and a dermal infiltrate with eosinophils and neutrophils. Lesions were treated with topical clobetasol propionate 0.05% for 10 days followed by topical tacrolimus daily until complete resolution, and then twice weekly for 1 year, without relapse. The response to topical corticosteroids and tacrolimus further support the close relationship with erosive pustular dermatosis of the scalp. Topical therapy with tacrolimus ...
Source: Australasian Journal of Dermatology - December 28, 2009 Category: Dermatology Authors: Elena Dall'Olio, Paolo Rosina, Giampiero Girolomoni Source Type: journals

Perrigo Confirms Filing For Generic Version Of Clobex® Spray And Announcement Of Lawsuit By Galderma And DermalogixEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Perrigo Company (Nasdaq: PRGO ; TASE) today announced that it has filed an Abbreviated New Drug Application for Clobetasol Propionate Topical Spray, 0.05%, a generic form of Clobex® Spray. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - December 9, 2009 Category: Pharmaceuticals Source Type: news

Severe 20-nail psoriasis successfully treated by low dose methotrexate.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
We report a case of severe psoriatic nail dystrophy involving all 20 nails successfully treated by low dose MTX. A previously healthy 11-year-old girl presented with painful deformity involving all 20 nails that developed over a one-month period. Examination revealed geographic and fissured tongue, as well as severe nail dystrophy of all 20 nails characterized by erythematous swelling of the nail folds, yellowish discoloration of nail plates with pitting, severe crumbling and destruction, transverse depressions, prominent oil spots, and swelling of proximal nail. Topical clobetasol propionate and calcipotriol were tried fi...
Source: Dermatol Online J - December 3, 2009 Category: Dermatology Authors: Lee JY Tags: Dermatol Online J Source Type: journals

CLOBETASOL PROPIONATEointment CLOBETASOL PROPIONATEcream CLOBETASOL PROPIONATEgel [E. FOUGERA CO., A Division Of Nycomed US Inc.]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Dec 2, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - December 2, 2009 Category: Drugs & Pharmacology Source Type: organizations

Clobetasol: Mood disorders in an elderly patient: case reportEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Reactions)
Source: Reactions - November 30, 2009 Category: Drugs & Pharmacology Tags: Short communication Source Type: journals

Ultrasound evaluation of clobetasol propionate 0.05% foam application in psoriatic and healthy skin: a pilot studyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The aim of the present study was to evaluate through ultrasound imaging the response to treatment of twice and once daily application of clobetasol propionate 0.05% foam on psoriatic skin as well as the atrophogenic potential of once daily application of the foam on healthy skin. The study included a total of 40 participants, 30 affected by Psoriasis vulgaris and 10 healthy volunteers. Patients with psoriasis were branched in two groups of 15 subjects: in the first group, clobetasol propionate 0.05% foam was applied twice daily for up to 2 weeks on targeted plaques, in the second group, it was applied once daily for up to ...
Source: Dermatologic Therapy - November 3, 2009 Category: Dermatology Authors: Francesco Lacarrubba, Beatrice Nardone, Maria Letizia Musumeci, Giuseppe Micali Tags: SIDeMaST Source Type: journals

CLOBETASOL PROPIONATEaerosol, Foam [DPT Laboratories, Ltd.]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Oct 26, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - October 26, 2009 Category: Drugs & Pharmacology Source Type: organizations

Treatment of scalp psoriasis with clobetasol-17 propionate 0.05% shampoo: a study on daily clinical practiceEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions Short-contact treatment with clobetasol-17 propionate 0.05% shampoo has high user convenience and patient satisfaction rates. Moreover, the treatment is well-tolerated and efficacious from patients' perspective. Subgroup analyses did not reveal factors predicting treatment outcome, although treatment success tended to be more evident in patients who had received fewer treatments previously. (Source: Journal of the European Academy of Dermatology and Venereology)
Source: Journal of the European Academy of Dermatology and Venereology - October 20, 2009 Category: Dermatology Authors: HJ Bovenschen, PCM Van de Kerkhof Source Type: journals

CLOBETASOL PROPIONATEsolution [E. FOUGERA CO. A Division Of Nycomed US Inc.]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Oct 20, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - October 20, 2009 Category: Drugs & Pharmacology Source Type: organizations

Topical Clobetasol Propionate in the Treatment of Psoriasis: A Review of Newer FormulationsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: American Journal of Clinical Dermatology)
Source: American Journal of Clinical Dermatology - October 16, 2009 Category: Dermatology Authors: Feldman, Steven R.Yentzer, Brad A. Tags: Review Articles Source Type: journals

Repeated mechanical trauma to the hands: the use of anti-impaction gloves for treatment and return to work.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CONCLUSION: Anti-impaction gloves are shown to aid in the return-to-work process for those with FHD but not for those with HHD. PMID: 19808004 [PubMed - in process] (Source: Dermatitis)
Source: Dermatitis - September 30, 2009 Category: Dermatology Authors: Kwok T, Arrandale V, Skotnicki-Grant S Tags: Dermatitis Source Type: journals

Double-blind, crossover, placebo-controlled clinical trial with clobetasol propionate in desquamative gingivitis.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The aim of this study was to evaluate the efficacy of a 0.05% clobetasol propionate ointment administered in trays to 22 patients with desquamative gingivitis in a double-blind, crossover, placebo-controlled trial. Patients received container number 1 and were instructed to apply the ointment 3 times a day for 2 weeks, and to reduce the application to once a day in the third week. Next, the patients were then instructed to discontinue the treatment for 2 weeks, and were then given container 2, used in the same way and for the same length of time as container 1. Regarding signs, 17 patients presented some improvement, w...
Source: Braz Dent J - September 29, 2009 Category: Dentistry Authors: Motta AC, Domaneschi C, Komesu MC, Souza Cda S, Aoki V, Migliari DA Tags: Braz Dent J Source Type: journals

TEMOVATE (Clobetasol Propionate) Solution [PharmaDerm, A Division Of Nycomed US Inc.]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Sep 24, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - September 24, 2009 Category: Drugs & Pharmacology Source Type: organizations

What's new in urticaria ?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Ghosh SanjayIndian Journal of Dermatology 2009 54(3):280-282Urticaria, a perplexing disease of ever-changing explanations, is being renovated almost everyday by newer facts and findings accumulated from different parts of the globe. Cost of the urticaria treatment gradually grows higher and higher whereas the ailment disturbs the quality of life very adversely. Disorder of coagulation cascade has recently thrown some new light into its mechanism. Non-allergic angioedema induced by bradykinin caused by genetic defects and ACE-inhibitors has also been noted. Role of <i> H. pylori </i> ...
Source: Indian Journal of Dermatology - September 10, 2009 Category: Dermatology Authors: Ghosh Sanjay Source Type: journals

CLOBETASOL PROPIONATEemulsion [Glenmark Generics Inc., USA]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Aug 26, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - August 26, 2009 Category: Drugs & Pharmacology Source Type: organizations

CLOBEX (Clobetasol Propionate) Shampoo [DPT Laboratories, Ltd.]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Aug 25, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - August 25, 2009 Category: Drugs & Pharmacology Source Type: organizations

CORMAX (Clobetasol Propionate) Ointment [DPT Laboratories, Ltd.]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Aug 25, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - August 25, 2009 Category: Drugs & Pharmacology Source Type: organizations

CLOBETASOL PROPIONATEaerosol, Foam [DPT Laboratories, Ltd.]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Aug 25, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - August 25, 2009 Category: Drugs & Pharmacology Source Type: organizations

CLOBETASOL PROPIONATEsolution [Glenmark Generics Inc., USA]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Aug 25, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - August 25, 2009 Category: Drugs & Pharmacology Source Type: organizations

CLOBETASOL PROPIONATEcream CLOBETASOL PROPIONATEointment [Glenmark Generics Inc., USA]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Aug 21, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - August 21, 2009 Category: Drugs & Pharmacology Source Type: organizations

Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trialEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions Raft modulators such as miltefosine are promising candidates for novel therapeutic strategies in patients with cutaneous mastocytosis. Future studies should be performed with improved formulations using nonirritant vehicles. (Source: British Journal of Dermatology)
Source: British Journal of Dermatology - August 2, 2009 Category: Dermatology Authors: K. Hartmann, F. Siebenhaar, B. Belloni, K. Brockow, R. Eben, B. Hartmann, F. Ruëff, N. Schoepke, P. Staubach, A. Weber, M. Maurer Source Type: journals

Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A 48-year-old woman presented with pruritic, scaly, annular plaques over her upper back and chest that were clinically, serologically and histologically characteristic of subacute cutaneous lupus erythematosus (SCLE). She failed to respond to conventional treatment, which included high-dose hydroxychloroquine, methotrexate, prednisolone, chloroquine, acitretin, thalidomide, dapsone and azathioprine. Subsequently treated with intravenous rituximab 375 mg/m(2) weekly for 4 weeks, she remained on adjuvant oral hydrochloroquine 600 mg daily and topical clobetasol propionate 0.05% ointment as required. Clearing of annular p...
Source: The Australasian Journal of Dermatology - July 31, 2009 Category: Dermatology Authors: Kieu V, O'Brien T, Yap LM, Baker C, Foley P, Mason G, Prince HM, McCormack C Tags: Australas J Dermatol Source Type: journals

Refractory subacute cutaneous lupus erythematosus successfully treated with rituximabEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A 48-year-old woman presented with pruritic, scaly, annular plaques over her upper back and chest that were clinically, serologically and histologically characteristic of subacute cutaneous lupus erythematosus (SCLE). She failed to respond to conventional treatment, which included high-dose hydroxychloroquine, methotrexate, prednisolone, chloroquine, acitretin, thalidomide, dapsone and azathioprine. Subsequently treated with intravenous rituximab 375 mg/m2 weekly for 4 weeks, she remained on adjuvant oral hydrochloroquine 600 mg daily and topical clobetasol propionate 0.05% ointment as required. Clearing of annular plaques...
Source: Australasian Journal of Dermatology - July 22, 2009 Category: Dermatology Authors: Violet Kieu, Timothy O'Brien, Lee-Mei Yap, Christopher Baker, Peter Foley, Graham Mason, H Miles Prince, Christopher McCormack Tags: CASE REPORTS Source Type: journals

CLOBETASOL PROPIONATEgel CLOBETASOL PROPIONATEcream CLOBETASOL PROPIONATEointment [E. FOUGERA CO.]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Jun 30, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - June 30, 2009 Category: Drugs & Pharmacology Source Type: organizations

Nanoencapsulation as a Way to Control the Release and to Increase the Photostability of Clobetasol Propionate: Influence of the Nanostructured SystemEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Journal of Biomedical Nanotechnology)
Source: Journal of Biomedical Nanotechnology - June 26, 2009 Category: Nanotechnology Authors: Fontana, M.C.Coradini, K.Guterres, S.S.Pohlmann, A.R.Beck, R.C.R. Tags: Research Articles Source Type: journals

CLOBETASOL PROPIONATEgel [Glenmark Generics Inc., USA]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Jun 24, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - June 24, 2009 Category: Drugs & Pharmacology Source Type: organizations

CLOBETASOL PROPIONATEgel CLOBETASOL PROPIONATEcream CLOBETASOL PROPIONATEointment [E. FOUGERA CO.]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Jun 23, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - June 23, 2009 Category: Drugs & Pharmacology Source Type: organizations

CLOBETASOL PROPIONATEsolution [E. FOUGERA CO.]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Jun 23, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - June 23, 2009 Category: Drugs & Pharmacology Source Type: organizations

Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort studyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion. The results of our small retrospective study suggest that TCPO may be more effective than either 0.1% tacrolimus or clobetasol propionate 0.05% ointment monotherapy in the treatment of recalcitrant CLE. Randomized controlled trials are needed to confirm these preliminary findings. (Source: Clinical And Experimental Dermatology)
Source: Clinical And Experimental Dermatology - June 21, 2009 Category: Dermatology Authors: V. Madan, P. J. August, R. J. G. Chalmers Source Type: journals

Clobevate (Clobetasol Propionate Gel) - new on RxListEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Clobevate (Clobetasol Propionate Gel) drug description - FDA approved labeling for prescription drugs and medications at RxList (Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 5, 2009 Category: Drugs & Pharmacology Source Type: consumer

Effect of Intracanal Corticosteroids on Healing of Replanted Dog Teeth after Extended Dry TimesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This study investigated the effect of potent intracanal corticosteroids on periodontal healing of replanted avulsed teeth and evaluated the systemic absorption of these corticosteroids. Sixty-seven extracted dog premolar roots were randomly assigned to one of the following groups: groups 1–3 filled with gutta-percha and replanted immediately and after 40 and 60 minutes, respectively; groups 4 and 5 filled with 0.05% clobetasol; and groups 6 and 7 filled with 0.05 % fluocinonide. Groups 4 and 6 were replanted after 40 minutes and groups 5 and 7 after 60 minutes. After 4 months, roots were evaluated histologically for sign...
Source: Journal of Endodontics - May 1, 2009 Category: Dentistry Authors: Anna Kirakozova, Fabricio B. Teixeira, Alice E. Curran, Fang Gu, Peter Z. Tawil, Martin Trope Tags: Biology Source Type: journals

[Efficacy of rituximab in a case of refractory bullous pemphigoid]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CONCLUSION: Rituximab could offer a safe and effective therapeutic alternative for refractory BP. PMID: 19442800 [PubMed - in process] (Source: Annales de Dermatologie et de Cenereologie)
Source: Annales de Dermatologie et de Cenereologie - April 30, 2009 Category: Dermatology Authors: Reguiaï Z, Tchen T, Perceau G, Bernard P Tags: Ann Dermatol Venereol Source Type: journals

Melanocytic proliferations associated with lichen sclerosus in adolescenceEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In this report, we describe the case of a prepubertal girl presenting with a junctional melanocytic nevus of the labia minora superimposed by lichen sclerosus. The lesion was completely excised and free margins confirmed by histological examination. After a 3 months course of topical clobetasol treatment the girl remained asymptomatic. No local recurrence was notified with a follow-up time of 12 months. Content Type Journal ArticleCategory Case ReportDOI 10.1007/s00404-009-1049-5Authors Stefanie Susanne Bussen, Women’s University Hospital of Mannheim Rathausstr. 25 68519 Viernheim Germany Journal...
Source: Archives of Gynecology and Obstetrics - March 28, 2009 Category: OBGYN Tags: Archives of Gynecology and Obstetrics Source Type: journals

Docetaxel: Dermatitis treated with clobetasol: case reportEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Reactions)
Source: Reactions - March 17, 2009 Category: Drugs & Pharmacology Tags: Short communication Source Type: journals

Docetaxel: Dermatitis treated with clobetasol: case report.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Page: 20 (Source: Reactions Weekly)
Source: Reactions Weekly - March 15, 2009 Category: Drugs & Pharmacology Tags: HTML Source Type: journals

Halobetasol versus clobetasol: A study of potencyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Mohandas Soumya, Rai Reena, Srinivas C RIndian Journal of Dermatology, Venereology and Leprology 2009 75(2):186-187 (Source: Indian Journal of Dermatology, Venereology and Leprology)
Source: Indian Journal of Dermatology, Venereology and Leprology - March 15, 2009 Category: Dermatology Authors: Mohandas Soumya, Rai Reena, Srinivas C R Source Type: journals

Galderma Announces Interim Data Relating To Sequential Treatment Regimen Of Clobex(R) Spray Followed By Vectical(TM) Ointment In Managing PsoriasisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Galderma Laboratories, L.P. announced interim findings from a study of sequential treatment of plaque psoriasis using Clobex(R) (clobetasol propionate) Spray 0.05% followed by treatment with Vectical(TM) (calcitriol) Ointment 3mcg/g. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 7, 2009 Category: Consumer Health News Tags: Dermatology Source Type: news

Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex Spray Followed by Vectical Ointment in Managing Plaque PsoriasisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN FRANCISCO, March 06, 2009 /PRNewswire/ -- Galderma Laboratories, L.P. today announced interim findings from a study of sequential treatment of plaque psoriasis using Clobex (clobetasol propionate) Spray 0.05% followed by treatment with... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 6, 2009 Category: Pharmaceuticals Source Type: news

Capsaicin vs. clobetasol for the treatment of localized alopecia areataEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Journal of the European Academy of Dermatology and Venereology)
Source: Journal of the European Academy of Dermatology and Venereology - March 5, 2009 Category: Dermatology Authors: AH Ehsani, S Toosi, H Seirafi, M Akhyani, M Hosseini, R Azadi, P Noormohamadpour, A Ghanadan Source Type: journals

Clobetasol: Cushing's syndrome in an infant: case report.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Page: 15 (Source: Reactions Weekly)
Source: Reactions Weekly - February 22, 2009 Category: Drugs & Pharmacology Tags: HTML Source Type: journals

Clobetasol: Cushing's syndrome in an infant: case reportEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Reactions)
Source: Reactions - February 22, 2009 Category: Drugs & Pharmacology Tags: Short communication Source Type: journals

Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Please cite this paper as: Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis. Experimental Dermatology 2009.Abstract: While glucocorticoids (GC) exert beneficial effects (anti-inflammatory), they also have adverse effects on the epidermis including decreased epidermal differentiation, decreased keratinocyte proliferation, and decreased cutaneous permeability barrier homeostasis. Thus, the purpose of this study was to develop strategies to prevent these GC toxicities using simultaneous topical treatments in clobetasol-treated mice. While a triple-lipid mixture of stratum ...
Source: Experimental Dermatology - February 19, 2009 Category: Dermatology Authors: Marianne Demerjian, Eung-Ho Choi, Mao-Qiang Man, Sandra Chang, Peter M. Elias, Kenneth R. Feingold Source Type: journals

Clobetasol: Cushing's syndrome with adrenal suppression in an elderly patient: case report.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Page: 11 (Source: Reactions Weekly)
Source: Reactions Weekly - February 15, 2009 Category: Drugs & Pharmacology Tags: HTML Source Type: journals

Clobetasol: Cushing's syndrome with adrenal suppression in an elderly patient: case reportEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Reactions)
Source: Reactions - February 15, 2009 Category: Drugs & Pharmacology Tags: Short communication Source Type: journals

CLOBETASOL PROPIONATEgel [Perrigo]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Jan 5, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - January 5, 2009 Category: Drugs & Pharmacology Source Type: organizations